Other namesTypes of channelopathy-associated CIPCausesSymptoms and signsDiagnostic testsNon-Pharmacological TreatmentsDrug Treatments for Complications of CIPDietary Molecular SupplementsImmune Booster, Regenerative and Stem Cell–Related Drug Concepts –Surgical ManagementPrevention and Lifestyle TipsWhen to See DoctorsWhat to Eat and What to AvoidFrequently Asked Questions (FAQs)Channelopathy-associated congenital insensitivity to pain is a very rare genetic condition where a person is born unable to feel physical pain, even when the body is badly hurt. “Channelopathy-associated” means the problem comes from a fault in tiny “channels” in nerve cells that control how electrical signals move. In this disease, the main channel that is affected is called Nav1.7, which is made by the SCN9A gene. When this channel does not work, pain messages cannot travel from the body to the brain, so the person never feels pain, even though touch and other senses can be normal. MedlinePlus+1In channelopathy-associated CIP, both copies of the SCN9A gene (one from each parent) are changed, so the NaV1.7 sodium channel is missing or does not work. This channel is normally found in pain-sensing nerves (nociceptors) in the dorsal root ganglia and in smell (olfactory) nerves. When NaV1.7 does not work, pain nerves cannot fire normal electrical signals, so the brain never “hears” the message that tissue is damaged. At the same time, the sense of smell is often completely lost (anosmia) because the same channel is important in smell nerves. The rest of the nervous system is mostly normal, so muscle strength and intelligence are usually fine, but the person’s daily life becomes risky because there is no natural warning system (pain) to protect the body from harm.MedlinePlus+1This condition usually starts from birth and lasts for life. Children may not cry or react when they fall, break a bone, burn their skin, or bite their tongue. Because pain is a warning sign that protects the body, not feeling pain leads to many injuries, chronic wounds, bone problems, and eye damage that may be noticed late. Many affected people also have a poor or absent sense of smell (anosmia) because the same sodium channel is important in the nerve cells of the nose. MedlinePlus+2NCBI+2Channelopathy-associated CIP is inherited in an autosomal recessive way. This means a child must receive one faulty SCN9A gene from each parent to be affected. The parents usually feel pain normally and are “carriers.” The condition is one of several forms of congenital insensitivity to pain, but it is special because the nerves look structurally normal and the main problem is the ion channel itself, not the loss of nerve fibres. NCBI+2NCBI+2Other namesChannelopathy-associated congenital insensitivity to pain has been described in the medical literature under several other names. These names all try to show that the person is born with a lifelong absence of pain because of a sodium channel defect. Commonly used names include “channelopathy-associated insensitivity to pain,” “congenital indifference to pain,” “congenital analgesia,” and “autosomal recessive asymbolia for pain.” Some older papers also use terms that overlap with hereditary sensory and autonomic neuropathy type V (HSAN V), although strictly speaking channelopathy-associated CIP is a separate, sodium-channel based condition. EJPD+2MedlinePlus+2Doctors may also write “SCN9A-associated congenital insensitivity to pain,” or “Nav1.7-related congenital inability to experience pain,” to remind themselves that the SCN9A gene and the Nav1.7 sodium channel are the key structures involved. These names help link the condition to other sodium channel diseases, such as SCN9A-related pain syndromes where the channel is overactive instead of underactive. Europe PMC+2OUP Academic+2Types of channelopathy-associated CIPDoctors usually group congenital insensitivity to pain into several major types based on the gene that is affected and on how the nerves look under the microscope. Channelopathy-associated CIP forms one main group in this larger family. In this group, the peripheral nerves are structurally normal, but the sodium channels in the pain-sensing nerves do not work correctly, so pain messages never start. NCBI+1One main type is SCN9A (Nav1.7) loss-of-function CIP. Here, both copies of the SCN9A gene have changes that stop the Nav1.7 channel from working. The person has a complete absence of pain from birth and almost always also has loss of smell. The rest of the nervous system examination is usually normal. This is the classic “channelopathy-associated congenital insensitivity to pain” first clearly described in families from Pakistan and later in many other populations. Europe PMC+2PMC+2A second, rarer type is SCN11A (Nav1.9)-related painlessness. In this form, a gain-of-function mutation in the SCN11A gene makes the Nav1.9 channel overactive in a special way. This constant activity keeps the pain-sensing nerve cells in a state where they cannot fire normal pain signals. These patients can also show congenital painlessness, self-injury, slow-healing wounds, joint problems, and bowel symptoms. Because it is also caused by a sodium channel error, it is often considered another “channelopathy-associated” painlessness syndrome. Springer Nature Link+2MDPI+2Researchers also suspect there may be other rare sodium channel–based painlessness types that have not yet been fully described. Studies of families with unusual pain problems continue to find new mutations in SCN9A and SCN11A, and these discoveries help scientists understand how these channels control pain in humans. MDPI+2OUP Academic+2CausesIn channelopathy-associated CIP, every “cause” is some kind of genetic or biological change that stops sodium channels, especially Nav1.7, from doing their job in pain-sensing nerves. Below, each cause is described as a separate factor, but all of them are connected to the same core idea: the pain channel does not work, so the brain never receives pain signals. MedlinePlus+2Europe PMC+2Biallelic SCN9A loss-of-function mutationsThe main cause is having damaging mutations in both copies of the SCN9A gene, one from each parent. These mutations make Nav1.7 either completely non-functional or severely reduced in function, so pain-sensing nerves cannot start electrical signals when the body is hurt. Europe PMC+1Nonsense mutations in SCN9ANonsense mutations create a “stop” signal too early in the gene, so the Nav1.7 protein is cut short and cannot form a working channel. This early stop removes important parts of the protein that are needed for sodium to pass through and for the channel to open and close correctly. Europe PMC+1Frameshift mutations in SCN9ASmall insertions or deletions in the SCN9A gene can shift the reading frame, producing a scrambled and usually useless protein. These frameshift changes often lead to early breakdown of the messenger RNA or produce a Nav1.7 channel that cannot be placed properly in the nerve cell membrane. Europe PMC+1Splice-site mutations in SCN9ASome mutations occur at the boundaries between exons and introns (splice sites). These errors lead to incorrect joining of gene segments, so the final Nav1.7 protein misses important sections or includes intron sequences. The resulting channel is unstable or inactive, preventing normal pain signaling. PMC+1Severe loss-of-function missense mutationsMissense mutations change one amino acid in the Nav1.7 protein. When the change hits a critical region, such as the pore or voltage sensor, it can prevent the channel from opening, from conducting sodium, or from staying in the membrane. Even a single important missense mutation in each copy of the gene can fully block the pain signal. PMC+1Compound heterozygous SCN9A mutationsMany patients carry two different damaging SCN9A variants, one on each chromosome. This is called compound heterozygosity. Together these two variants remove Nav1.7 function enough to cause complete painlessness, even if each single variant alone might be less severe. PMC+1Homozygous mutations due to carrier parentsIn some families, both parents silently carry the same faulty SCN9A mutation. When a child inherits the mutated gene from both parents, they become homozygous and show the full channelopathy-associated CIP phenotype with complete lack of pain. Europe PMC+1Consanguineous marriage increasing riskIn populations where marriages between relatives are common, there is a higher chance that both parents carry the same rare SCN9A mutation. This makes homozygous channelopathy-associated CIP more frequent in certain villages or ethnic groups compared with the general population. Europe PMC+2OUP Academic+2Founder mutations in isolated populationsSome regions have “founder” SCN9A mutations that were introduced by a distant ancestor and then spread within a relatively closed community. These founder mutations cause several families in the same region to have the same genetic cause of channelopathy-associated CIP. Europe PMC+1Mutations affecting the pore of Nav1.7Changes in the pore-forming part of Nav1.7 can stop sodium ions from entering the cell, even if the channel opens. Without sodium flow, the nerve cannot fire an action potential, so pain signals never start, leading to congenital painlessness. Wikipedia+1Mutations affecting voltage-sensor segmentsOther mutations affect the voltage-sensing helices of Nav1.7. These segments help the channel detect changes in membrane voltage and open at the right time. When they are damaged, the channel may never open during normal painful stimuli, blocking pain signaling. Wikipedia+1Mutations that prevent channel traffickingSome SCN9A variants make Nav1.7 so unstable that it cannot travel correctly from inside the cell to the surface membrane. If the channel is trapped inside the cell and never reaches the nerve ending, pain signals cannot be generated. PMC+1Mutations that abolish current at body temperatureCertain mutations may allow a small current in laboratory tests at cold temperatures but no useful current at human body temperature. In real life, this means Nav1.7 does not function in the body, so pain-sensing neurons stay silent even when tissue is damaged. OUP Academic+1Nav1.7 dysfunction in dorsal root ganglion neuronsDorsal root ganglion (DRG) neurons carry pain messages from the body to the spinal cord. SCN9A mutations that remove Nav1.7 function in these neurons stop them from reaching the threshold to fire, so hurtful stimuli such as cuts, burns, or fractures never create a painful sensation. Europe PMC+1Nav1.7 dysfunction in trigeminal neuronsNav1.7 is also strongly expressed in trigeminal ganglion neurons, which carry pain signals from the face, tongue, teeth, and eyes. When Nav1.7 is absent or non-functional here, injuries in the mouth, eyes, and face do not feel painful, leading to tongue biting, dental trauma, and unrecognized eye injuries. MedlinePlus+2PMC+2Nav1.7 dysfunction in olfactory neurons (anosmia)The same SCN9A mutations affect pain and smell because Nav1.7 is present in olfactory nerve terminals. Loss of Nav1.7 in these cells blocks smell signal transmission, causing anosmia, which is a common feature in channelopathy-associated CIP. PubMed+2American Academy of Neurology+2SCN11A (Nav1.9) gain-of-function channelopathyIn some families with congenital painlessness, the cause is a gain-of-function mutation in SCN11A (Nav1.9). These mutations keep the channel abnormally active, causing a constant depolarized state that paradoxically makes pain-sensing neurons unable to fire normal action potentials. This also produces a channelopathy-based insensitivity to pain. Springer Nature Link+2MDPI+2Gene variants that change channel gating kineticsSome mutations alter how fast the sodium channel opens and closes (gating kinetics). If the channel opens too slowly or inactivates too quickly, the nerve cannot generate a strong enough electrical spike in response to painful events, so pain is not felt. Springer Nature Link+1Modifier genes and background genetic factorsResearch suggests that other genes in the pain pathway may modify how severe the painlessness is in people with SCN9A or SCN11A mutations. Although these modifier genes do not cause the disease alone, they may influence joint damage, wound healing, or other complications in channelopathy-associated CIP. OUP Academic+1Extremely rare de novo mutationsIn a few cases, the disease-causing mutation in SCN9A or SCN11A may arise “de novo” (new) in the sperm or egg, so the parents do not carry the variant. The child is still affected because both gene copies are damaged (for example, one inherited and one new), resulting in the same channelopathy-associated painlessness phenotype. OUP Academic+2Nature+2Symptoms and signsPeople with channelopathy-associated CIP share a core symptom: they cannot feel pain. Around this main feature there are many other signs and complications that develop over time because injuries are not noticed. MedlinePlus+2NCBI+2Complete inability to feel painFrom birth, affected individuals do not show pain when they fall, cut themselves, or have injections. They react normally to touch and sometimes to temperature, but the “hurt” feeling that others experience is completely absent in all body parts. MedlinePlus+2NCBI+2Normal or near-normal sense of touchRoutine examination usually shows that light touch, vibration, and joint position sense are normal. This means the problem is not a full sensory neuropathy, but a very specific loss of pain (and sometimes temperature) signals, linked to the faulty sodium channel. NCBI+1Self-inflicted injuriesChildren often bite their tongue, lips, and fingers without realizing it. They may put sharp objects into the skin, bang their head, or pick at wounds. Because there is no pain, they repeat these actions, causing ulcers, scars, and deformities. Wikipedia+2PMC+2Painless bone fracturesMany patients develop fractures without any complaint of pain. Parents or doctors may only notice when the child limps, refuses to bear weight, or has swelling. Repeated unnoticed fractures are a classic sign of CIP. PMC+2PubMed+2Joint deformities and Charcot jointsBecause fractures and joint injuries are not rested or treated, the bones and joints heal in the wrong position. Over time this can lead to severe deformities and “Charcot joints,” where the joint becomes enlarged, unstable, and badly damaged. MedlinePlus+2PMC+2Chronic wounds and skin infectionsCuts, burns, and pressure sores are common and may be discovered late. Without the warning of pain, people may continue to walk on an injured foot or rub a sore area, leading to chronic ulcers and recurrent infections. National Organization for Rare Disorders+2PMC+2Eye injuries and corneal damageMany patients rub their eyes or touch them with fingers or objects without feeling discomfort. The blink and corneal reflex can be reduced, and foreign bodies or scratches on the cornea may go unnoticed, leading to scarring and vision loss. MedlinePlus+2Monarch Initiative+2Dental and oral problemsSelf-biting, tongue injuries, and unrecognized dental trauma can lead to missing teeth, broken teeth, and chronic mouth ulcers. Bite wounds may become infected because pain does not remind the person to protect or clean the area. EJPD+2Cureus+2Loss of sense of smell (anosmia)Most people with SCN9A-related channelopathy-associated CIP have a reduced or completely absent sense of smell. This happens because Nav1.7 is also vital in olfactory neurons, so smell signals do not reach the brain properly. PubMed+2American Academy of Neurology+2Reduced corneal reflexSome patients have an absent or weak corneal reflex, meaning the eye does not blink normally when touched lightly. This is another sign of disturbed sensory signaling, and it contributes to eye injuries. Monarch Initiative+1Lack of fever or pain with infectionsBecause pain is absent, serious infections such as bone infections (osteomyelitis) or deep soft-tissue infections may progress silently. The person may not complain until there is obvious swelling, deformity, or disability. MedlinePlus+2PMC+2Limping or refusal to use a limb without pain complaintIn toddlers and children, a parent may notice that the child suddenly stops using an arm or leg, or walks oddly, but does not cry. This pattern often reflects an underlying fracture or joint injury discovered only on X-ray. PMC+2Cureus+2Normal intelligence in most casesMost people with channelopathy-associated CIP have normal intelligence and normal brain structure. This helps doctors distinguish the condition from some other forms of congenital insensitivity to pain that include developmental delay. Nature+1Risk-taking behaviourSince pain does not limit activity, some patients may naturally take more physical risks, such as rough play, extreme sports, or handling hot objects, without fear. This behaviour is usually not due to a psychological problem, but simply to the absence of pain warning signals. National Organization for Rare Disorders+1Shortened life expectancy due to complicationsOver a lifetime, repeated infections, bone damage, and accidental injuries can reduce life expectancy in people with CIP compared with the general population, although exact numbers are hard to measure because the condition is so rare. Wikipedia+1Diagnostic testsThere is no single simple blood test that alone confirms channelopathy-associated CIP. Doctors usually start with a careful history and physical examination, looking for lifelong lack of pain, frequent injuries, and anosmia. To confirm the diagnosis and rule out other diseases, they use a mix of bedside sensory tests, blood tests, nerve studies, imaging, and finally genetic testing for SCN9A and sometimes SCN11A or broader pain genes. MDPI+3NCBI+3FTR Dergisi+3Below are 20 important diagnostic tests, grouped by category, with simple explanations of what each one checks and why it matters.Physical examination testsFull general physical examinationThe doctor examines the whole body, checking growth, weight, posture, skin, and signs of old scars or deformities. Seeing many scars, burns, healed fractures, or missing fingertips in a person who never complains of pain strongly suggests a condition like CIP. NCBI+2PMC+2Detailed neurological examinationA neurological exam tests strength, reflexes, sensation (touch, vibration, position), and coordination. In channelopathy-associated CIP, most parts of the neurological exam are normal except for pain sensation and sometimes temperature, which helps distinguish this condition from broader neuropathies that affect many sensory types. NCBI+2Nature+2Cranial nerve and smell assessmentThe doctor checks cranial nerves, including smell by asking the person to identify different odours. Loss of smell together with complete painlessness is a strong clue for SCN9A-related channelopathy-associated CIP, because both pain and smell rely on Nav1.7 channels. PubMed+2American Academy of Neurology+2Musculoskeletal and joint examinationThe doctor looks for swelling, deformities, abnormal joint shapes, reduced movement, and differences in limb length. Painless fractures and Charcot-type joints (severely damaged, unstable joints) are common in CIP, and their presence guides the clinician to order imaging tests. PMC+2PubMed+2Skin and eye surface inspectionThe skin is checked for wounds, ulcers, calluses, and infection, especially on hands and feet. The doctor also inspects the eyes for redness, scars on the cornea, or signs of previous injury. These findings, combined with no pain history, support the suspicion of congenital painlessness. MedlinePlus+2Monarch Initiative+2Manual bedside sensory testsPinprick and sharp-dull discrimination testThe clinician lightly touches the skin with a safety pin (sharp end and blunt end) and asks the patient to say “sharp” or “dull.” People with channelopathy-associated CIP can usually tell that something touches the skin but cannot correctly feel “sharp” as painful, indicating a specific loss of nociception. NCBI+2Nature+2Light touch testing with cotton or monofilamentA piece of cotton or a soft nylon filament is used to test light touch. In CIP, light touch is generally normal, so the patient feels the cotton but not the pain from the pin. This contrast between normal touch and absent pain is a key feature of channelopathy-based CIP. NCBI+1Temperature discrimination testThe doctor applies test tubes or metal objects at safe warm and cool temperatures to the skin and asks whether they feel warm or cold. Some people with channelopathy-associated CIP can still feel temperature differences, while others have reduced heat pain. This pattern helps separate different types of congenital pain disorders. MedlinePlus+2Wikipedia+2Pressure pain threshold testGentle pressure is applied over muscles or joints, sometimes with a simple handheld device. In typical people, enough pressure becomes uncomfortable or painful, but individuals with CIP often report only pressure, never pain, even at high levels, showing the absence of normal pain responses. MDPI+1Corneal sensitivity and blink testA very soft wisp of cotton is lightly touched to the eye surface to see whether the person blinks or feels discomfort. In some CIP patients, this reaction is reduced or absent, which matches the tendency to develop unrecognized corneal injuries and supports a diagnosis of a sensory channel disorder. Monarch Initiative+2NCBI+2Laboratory and pathological testsTargeted SCN9A genetic testingThe most important confirmatory test is DNA sequencing of the SCN9A gene to look for biallelic loss-of-function variants. Modern genetic laboratories can detect point mutations and small deletions or duplications with very high sensitivity, giving a clear molecular diagnosis of channelopathy-associated CIP when pathogenic variants are found. Cureus+2Fulgent Genetics+2Extended pain gene panel or exome sequencingIf SCN9A testing is negative but CIP is strongly suspected, doctors may use a broader panel that includes SCN11A and other pain-related genes, or whole exome sequencing. This can detect rare Nav1.9 mutations or other causes of congenital painlessness, and helps separate channelopathy-associated CIP from other forms. MDPI+2OUP Academic+2Routine blood tests to rule out acquired causesBlood tests such as complete blood count, vitamin B12, fasting glucose, thyroid function, and infection markers are often done to exclude acquired neuropathies, diabetes, vitamin deficiency, or inflammatory diseases that can also reduce pain sensation. Normal results support a congenital, genetic cause. NCBI+1Nerve biopsy (used rarely)In some older reports, doctors took a small biopsy of a sensory nerve to look for structural damage. In channelopathy-associated CIP, the nerve fibres usually look normal, which fits with a channel defect rather than nerve loss. Today, invasive nerve biopsy is less common because genetic testing is safer and more precise. NCBI+2FTR Dergisi+2Skin biopsy for intraepidermal nerve fibre densityA small punch of skin can be examined to count small nerve fibres in the outer skin layer. In channelopathy-associated CIP, these nerve fibres are often preserved, which again shows that the main problem is not nerve loss but failure of sodium channels in otherwise present nociceptors. MDPI+2NCBI+2Electrodiagnostic testsNerve conduction studies (NCS)NCS measure how fast and how strongly electrical signals travel along peripheral nerves. In channelopathy-associated CIP, results are usually normal because large myelinated fibres are intact. Normal NCS in a person with complete painlessness pushes doctors to think of channelopathies rather than classic neuropathies. FTR Dergisi+2NCBI+2Electromyography (EMG)EMG uses small needles to record muscle electrical activity. It helps exclude muscle diseases or motor nerve problems. In channelopathy-associated CIP, EMG studies are typically normal, supporting the conclusion that the problem is limited to pain-sensing pathways and not the motor system. FTR Dergisi+1Quantitative sensory testing (QST)QST uses controlled devices to measure thresholds for heat, cold, and mechanical pain. Patients with channelopathy-associated CIP show very high or absent pain thresholds while touch thresholds may be near normal. This detailed profile helps document the unique selective pain loss and supports research into sodium channel roles in human pain. MDPI+2Nature+2Imaging testsX-rays of bones and jointsPlain X-rays are used to detect fractures, bone deformities, and joint destruction in people who do not report pain. Many CIP patients show old, healed fractures and Charcot-like joints, especially in the ankles, feet, and knees, even though they never remember a painful injury. PMC+2PubMed+2Magnetic resonance imaging (MRI) or CT scansMRI or CT is used when doctors need a more detailed picture of joints, spine, or brain. These scans help assess the full extent of bone and joint damage, look for osteomyelitis (bone infection), and rule out other neurological diseases. Imaging findings, together with life-long painlessness and genetic results, confirm the diagnosis of channelopathy-associated CIP. PMC+2Cureus+2Non-Pharmacological Treatments1. Lifelong safety and education programA core non-drug treatment is constant education for the child, family, teachers, and caregivers about living safely without pain. This includes teaching that “no pain does NOT mean no injury,” explaining how to check the body every day, and creating simple rules such as using oven gloves, avoiding barefoot walking, and reporting any new swelling or redness. Regular teaching sessions help the child grow up understanding their unique condition and reduce risky behaviors like rough play, biting body parts, or walking on injuries.NCBI+12. Daily whole-body skin and joint checksBecause injuries may not hurt, a daily head-to-toe skin and joint inspection is essential. Parents and, later, the patient learn to look for swelling, bruises, cuts, blisters, deformities, and changes in walking style. Any new change is treated as a possible injury until a doctor rules it out. Doing this every day, often after bathing and before sleep, allows early detection of fractures, infections, and pressure sores, which can otherwise become life-threatening if ignored.Cureus+13. Protective footwear and orthotic devicesSpecial shoes with extra padding and strong soles protect the feet from cuts, foreign bodies, and repetitive stress, especially because many patients develop foot deformities. Orthotic inserts and custom boots can support unstable joints and reduce abnormal pressure on bones. This mechanical protection lowers the risk of fractures, ulcers, and bone infections in the feet and ankles, which are very common in people who feel no pain when they walk on injuries.Physiopedia+14. Helmet and body protectors for high-risk activitiesHelmets, knee pads, elbow pads, and sometimes padded vests are recommended when the person engages in physical activity such as cycling, running games, or sports. Because pain does not warn them to slow down or stop, they may continue playing after a serious fall. Protective gear helps absorb impact, reducing the chance of head injury, fractures, or internal damage during everyday activities and school play.Physiopedia+15. Environmental safety planning at home and schoolNon-pharmacological care includes modifying the home and school so they are safer. Simple steps include covering sharp corners, using child-proof guards on heaters and stoves, setting maximum safe water temperature on taps, adding non-slip flooring, and avoiding glass doors. Teachers can adapt school activities to avoid extreme heat, cold, or impact. This environmental planning lowers the number of dangerous situations before they happen.NCBI+16. Regular orthopedic monitoring and physiotherapyOrthopedic specialists and physiotherapists follow the patient over years to watch for joint deformities, scoliosis, bone infections, or abnormal gait. Regular X-rays and physical exams help find problems early. Physiotherapy programs with gentle muscle strengthening and stretching improve joint stability, balance, and posture, which can reduce falls and limit long-term disability, even though the patient does not feel pain during exercises.MDPI+17. Dental and oral care programsPeople with CIP may bite their tongue, lips, or cheeks without noticing, and can fracture teeth by chewing very hard foods. A special dental plan includes frequent dental visits, mouth guards at night if needed, careful brushing, and avoiding very hard or sharp foods. Dentists watch for tooth decay, gum disease, and bite injuries, treating them early to prevent infections that could spread to the jawbone.NCBI+18. Eye protection and ophthalmology follow-upBecause corneal scratches and foreign bodies in the eye may not hurt, eye injuries are a serious risk. Protective glasses or goggles are useful for outdoor play, dusty work, or sports. Regular visits to an eye doctor help detect dry eye, corneal ulcers, or infections early. Lubricating eye drops, eyelid hygiene, and quick treatment of any redness or discharge can protect vision long-term.NCBI+19. Temperature regulation and heat protectionSome people with CIP, especially those overlapping with CIPA, have problems regulating body temperature and may not feel burns. Families are taught to avoid very hot baths, to always check water temperature with a thermometer or caregiver’s hand, and to prevent long stays in hot environments. Light clothing, fans, and hydration help during hot weather. These simple steps lower the risk of heat stroke and burns.Physiopedia+110. Behavioral training to avoid self-injuryYoung children with CIP sometimes chew their fingers, lips, or tongue because they do not feel pain. Behavioral therapy uses positive reinforcement, distraction, and sometimes soft mittens or guards to break these habits. Psychologists and behavioral therapists work with families to build safe replacement behaviors, such as chewing safe toys or using sensory activities that do not injure the body.Physiopedia+111. Occupational therapy for safe daily activitiesOccupational therapists help adapt daily living tasks such as cooking, cleaning, and hobbies to reduce injury risk. They introduce tools with guards, safer kitchen layouts, and routines for checking the skin after tasks. They also teach problem-solving skills so patients can plan safe ways to do new activities without relying on pain as a warning. This improves independence while keeping safety in mind.NCBI+112. School and workplace support plansFor older children and adults, individualized education plans and workplace accommodations are important. Teachers and employers can agree on rules such as no barefoot walking, avoiding very hot equipment, and immediate reporting of falls or blows. A clear school or workplace health plan ensures that if an injury is suspected, the person is quickly evaluated, even if they say they “feel fine” because they do not feel pain.National Organization for Rare Disorders+113. Psychological support and counselingLiving with a rare condition can cause stress, anxiety, or social isolation. Psychologists and counselors provide a safe space to talk about fears, frustration, or bullying, and teach coping skills. Support groups (in person or online) allow families to share experiences and practical tips. Mental health care is evidence-based and improves quality of life and adherence to safety routines.National Organization for Rare Disorders+114. Family training in first aid and wound careFamilies are trained in basic first aid: cleaning wounds, applying dressings, immobilizing suspected fractures, and recognizing signs of infection like redness, warmth, and pus. Having a small “home wound kit” and clear instructions reduces delays between injury and treatment. Prompt basic care is vital because the patient may continue using an injured limb without pain, which can worsen damage.社会福祉法人日本心身障害児協会+115. Structured physical activity with supervisionExercise is still important for heart health, bone strength, and mood. The goal is not to avoid activity but to do it safely. Supervised sports chosen for low collision risk (like swimming with supervision, cycling with helmet, or walking) are encouraged. Coaches and trainers are informed about the condition and taught to check for injuries instead of waiting for pain complaints.Physiopedia+116. Orthopedic bracing and early casting of fracturesWhen fractures or joint problems occur, early immobilization with casts or braces protects the bone while it heals, even though the patient may not feel pain. Longer or stricter immobilization than usual is sometimes needed because the patient might still put weight on the limb unless carefully instructed and monitored. Proper casting reduces deformities and chronic disability.MDPI+117. Pressure-relief strategies to prevent soresDuring long travel, illness, or surgery, people with CIP may develop pressure sores because they do not feel discomfort and do not shift position. Nurses and caregivers use soft padding, regular repositioning, and pressure-relief mattresses or cushions to spread body weight. These methods are well-known in other conditions with low sensation and work similarly here to prevent skin breakdown.Orphan Anesthesia+118. Vaccination and infection-prevention routinesAlthough CIP is not an immune disease, repeated injuries increase infection risk in skin, bones, and joints. Standard vaccinations, including tetanus boosters and vaccines against common bacteria and viruses, are very important. Good hand hygiene, careful wound cleaning, and dental hygiene also help prevent infections that might not be painful at first but can become serious if ignored.MDPI+119. Multidisciplinary clinic follow-upThe best care is usually provided by a team including pediatricians, neurologists, orthopedists, dentists, ophthalmologists, physiotherapists, psychologists, and specialized nurses. Regular visits to a multidisciplinary clinic allow the team to share information and adjust the plan as the child grows. Evidence from rare-disease centers shows that this team approach reduces complications and hospitalizations.NCBI+120. Genetic counseling for family planningBecause the condition is autosomal recessive, parents who carry SCN9A mutations have a 25% chance of having another affected child with each pregnancy. Genetic counseling explains these risks in clear language and discusses options such as carrier testing for relatives and prenatal or preimplantation genetic testing for future pregnancies. This helps families make informed choices based on accurate medical information.NCBI+1Drug Treatments for Complications of CIPVery important: There is no specific approved drug that cures channelopathy-associated CIP. Treatment is supportive and focuses on infections, bone problems, eye disease, and other complications. Any drug must be prescribed and dosed by a qualified doctor; the brief dosing comments below are general educational descriptions, not instructions for self-treatment.NCBI+1I will list examples of drug types commonly used for complications in CIP, with information drawn from FDA prescribing information for those medicines where possible.1. Amoxicillin (AMOXIL®) for skin and soft-tissue infectionsAmoxicillin is a penicillin-type antibiotic used to treat many bacterial infections, including some skin, soft-tissue, and dental infections. In CIP, unnoticed cuts, ulcers, or dental injuries can become infected, so amoxicillin may be chosen when bacteria are sensitive. The doctor selects the dose and timing according to age, weight, and infection site, following the official FDA label. The purpose is to kill bacteria, reduce infection, and protect bone and joints. Common side effects include stomach upset, diarrhea, and allergic reactions in those who are sensitive to penicillins.FDA Access Data2. Amoxicillin-clavulanate (AUGMENTIN®) for mixed infectionsAmoxicillin-clavulanate combines a penicillin antibiotic with a beta-lactamase inhibitor to cover more types of bacteria, including some that resist plain amoxicillin. In CIP, this combination may be used for complicated skin or bone infections, bite wounds in the mouth, or joint infections caused by mixed bacteria. The goal is to treat infection aggressively to prevent deformity. Dosing schedules follow FDA labeling and vary by age and kidney function. Common side effects are diarrhea, nausea, and, rarely, liver irritation or allergic reactions.FDA Access Data3. Cefazolin for injection for bone and joint infectionsCefazolin is a first-generation cephalosporin antibiotic given by vein. It is FDA-approved for skin, bone, and joint infections caused by sensitive bacteria such as Staphylococcus aureus. In CIP, deep infections of bone (osteomyelitis) and joints can occur after unnoticed fractures or ulcers, and cefazolin is frequently used in hospital treatment. Doctors choose the dose and interval based on age, kidney function, and infection severity, strictly following the label. Side effects may include allergic reactions, diarrhea, or changes in blood tests.FDA Access Data+14. Broader-spectrum intravenous antibiotics (e.g., ceftriaxone)In severe sepsis or complicated bone infections in CIP, broader-spectrum antibiotics such as ceftriaxone or similar agents may be used. These drugs cover a wide range of bacteria while doctors wait for culture results. The purpose is to control infection early to save bone, joints, and life. Dosing is tailored to body weight and kidney or liver function according to FDA labels. Side effects can include diarrhea, liver enzyme changes, or rare allergic reactions, so careful monitoring is needed.MDPI5. Topical antibiotic creams for minor skin infectionsFor small infected cuts or abrasions, topical antibiotic ointments or creams may be used along with cleaning and dressings. These products help reduce local bacterial growth on the skin surface. They are applied in thin layers a few times per day as advised by a doctor or nurse. Side effects are usually mild and may include local redness or allergy. They do not replace systemic antibiotics for deep or serious infections but can assist early local treatment.MDPI6. Lubricating eye drops and antibiotic eye dropsLubricating artificial tears protect the cornea from drying and micro-trauma in people who may not blink or react to foreign bodies. If an eye infection or ulcer is present, antibiotic eye drops may be used to kill bacteria. Dosing frequency (for example, several times per day) is chosen by the eye specialist. The purpose is to prevent corneal scarring and vision loss. Mild stinging or blurred vision right after dropping can occur.NCBI+17. Bisphosphonates (e.g., alendronate) in selected cases of bone fragilitySome patients with repeated fractures and bone loss may develop osteoporosis-like changes. Bisphosphonates such as alendronate (FOSAMAX®) are FDA-approved for osteoporosis and work by slowing bone breakdown and improving bone density. In very carefully selected CIP patients with clear bone loss, an expert might consider similar therapy, always off-label and with close monitoring. Doses are usually once weekly or once daily according to the label, and patients must follow strict instructions (such as staying upright after swallowing). Side effects include stomach irritation and, rarely, jaw bone problems.FDA Access Data+18. Analgesics for other types of discomfortAlthough people with CIP do not feel typical pain, they can still experience headache, abdominal discomfort, or other sensations. Common analgesics such as paracetamol (acetaminophen) or certain non-steroidal anti-inflammatory drugs (NSAIDs) may still be used for these complaints, but doctors use them very carefully because lack of pain can hide serious disease. The purpose is to improve comfort, not to treat the CIP itself, and doses follow standard age-based guidance. Side effects depend on the drug (for example, liver effects with too much paracetamol).Wikipedia9. Naloxone and other opioid antagonists in research settingsNaloxone is an opioid-blocking drug approved by the FDA for emergency treatment of opioid overdose. Small studies and case reports suggest that naloxone or naltrexone may temporarily restore some pain sensation in people with NaV1.7-related CIP, possibly by reducing the effect of natural opioids in the body. However, this is experimental, not a routine treatment, and should only occur in research hospitals with careful monitoring. Standard naloxone dosing is based on overdose protocols in the FDA label and is not designed for long-term treatment of CIP. Side effects can include withdrawal symptoms in people using opioids.WebMD+110. Antipyretics for fever control during infectionsDuring infections, people with CIP may still develop fever even though they lack pain. Antipyretic medicines like paracetamol can lower fever and improve overall feelings of illness, but doctors must still search for the underlying cause because the patient may not complain of pain at the infection site. Over-use can damage the liver, so dosing must follow weight-based medical advice and the product label.Cureus+111. Local anesthetics for surgery and proceduresEven though the patient does not feel pain, local anesthetics and general anesthesia are often still used for surgery because tissues can still react, and there may be autonomic responses such as blood pressure changes. Anesthesia teams follow rare-disease guidelines that emphasize careful handling to avoid pressure injuries and temperature problems. Side effects are the usual anesthetic risks, so specialized anesthesiologists are recommended.Orphan Anesthesia12. Other antibiotics and supportive drugs as neededDepending on culture results and local guidelines, many other FDA-approved antibiotics or supportive drugs (like proton-pump inhibitors to protect the stomach, or anticoagulants to prevent clots after surgery) may be used. These drugs are chosen for general medical reasons, not specifically because of CIP. Doctors match the drug to the infection or problem, follow official labels for dose and timing, and watch closely for side effects because the patient may not feel pain as an early warning.MDPIDietary Molecular SupplementsSupplements should never replace proper medical care. Always discuss them with a doctor, especially for a rare disease like CIP.Vitamin D – Supports bone mineralization and immune function. In CIP, repeated fractures and limited outdoor activity can increase the risk of low vitamin D, so supplementation under medical guidance may support bone health and help reduce fracture risk.Calcium – Works together with vitamin D to build and maintain strong bones. Adequate calcium intake from food or supplements is important when bones are under repeated stress from unnoticed injuries.Omega-3 fatty acids (fish oil) – May support joint health, reduce inflammation, and benefit heart and brain function. They do not treat CIP directly but can help overall health in people who may have reduced physical activity due to orthopedic problems.Vitamin C – Important for collagen formation and wound healing. Because skin and soft-tissue injuries are common in CIP, adequate vitamin C from diet or supplements may help tissues repair more efficiently.Zinc – Helps immune function and wound healing. Zinc deficiency can delay healing of ulcers and fractures, so checking levels and supplementing if low may be useful.Vitamin K (dietary levels) – Essential for normal blood clotting and bone metabolism. A balanced diet with green leafy vegetables supports these functions; targeted supplements may be considered if levels are low.B-complex vitamins – B vitamins are important for nerve function and energy metabolism. While they do not fix the genetic problem in CIP, correcting any deficiency supports overall nerve health.Magnesium – Supports muscle and nerve function and works with calcium in bone. Adequate magnesium may help reduce muscle cramps and support bone strength in people with limited mobility.Protein supplements (if needed) – Adequate protein intake is crucial for muscle maintenance and tissue repair after injuries or surgery. In patients with poor appetite or increased needs, medical nutrition shakes may assist under dietitian guidance.Probiotics – May support gut health, especially in patients who often receive antibiotics for infections. A healthier gut microbiome may reduce antibiotic-associated diarrhea and improve nutrient absorption.MDPIImmune Booster, Regenerative and Stem Cell–Related Drug Concepts –No specific “immunity booster drug” for CIP – There is no evidence-based specific immune-boosting medicine approved just for CIP. The best “immune support” is vaccination, good nutrition, sleep, and infection control. Any product promising to “cure” CIP by boosting immunity should be viewed with great caution.MDPIStandard vaccines as immune protection – Routine vaccines (against tetanus, pneumococcus, influenza, etc.) are strongly recommended to reduce infection risk from wounds and surgeries. These vaccines are proven, regulated biological products that train the immune system to recognize germs.MDPIRegenerative orthopedics (bone grafts and growth factors) – When bones are badly damaged or infected, orthopedic surgeons may use bone grafts or bone-stimulating techniques (such as bone graft substitutes or growth-factor-coated materials) to help bone regenerate. These methods are used in many orthopedic conditions, not just CIP, and aim to restore bone strength and alignment.MDPIExperimental gene-therapy ideas targeting NaV1.7 – Research on NaV1.7 has shown that loss-of-function mutations cause CIP and that blocking this channel produces strong analgesia. Scientists are exploring gene-based approaches to adjust NaV1.7 function in other pain conditions, but at present there is no approved gene therapy to correct NaV1.7 mutations in CIP. All such approaches remain experimental in animal or early human studies.Cell+1Experimental modulation of endogenous opioid systems – Studies show that people with NaV1.7-related CIP have increased natural opioids. Blocking these with opioid antagonists like naloxone in research settings can temporarily restore some pain perception. This suggests future regenerative or neuromodulation strategies, but it is not yet a standard long-term treatment.PubMed+1Future stem cell and nerve-repair research – In theory, stem-cell-based therapies might one day help repair or replace damaged sensory neurons in some neuropathies. However, for CIP caused by SCN9A mutations, the main problem is the gene itself, not just loss of cells. At present, there are no approved stem-cell drugs for CIP, and any discussion of stem cells is purely research-level and must occur in specialist centers or clinical trials.Taylor & Francis Online+1Surgical ManagementFracture fixation (internal or external) – Because fractures in CIP may be severe or delayed in diagnosis, surgery is often needed to realign and stabilize bones with plates, screws, or external fixators. The purpose is to restore alignment, allow proper healing, and preserve function. Surgeons must use strong fixation and careful post-operative protection because the patient may walk on the limb without pain.MDPIDebridement of infected bone and soft tissue – In cases of chronic osteomyelitis or deep ulcers, surgery to remove dead bone and tissue (debridement) helps control infection and allows healthy tissue to grow. It is followed by long courses of antibiotics and careful wound care. The aim is to save the limb and prevent systemic infection.MDPI+1Corrective osteotomy for joint deformitiesLong-standing unnoticed fractures and joint damage can cause bone angulation and deformity, especially in knees and ankles. Corrective osteotomy means cutting and repositioning bones, then fixing them in a better position. This improves limb alignment, walking ability, and reduces the risk of future ulcers in overloaded areas.MDPIEye surgery for corneal damageSevere, repeated corneal ulcers or perforations may require surgical treatments such as corneal grafts or other reconstructive eye surgeries. The goal is to save the eye structure and protect or improve vision. Ophthalmologists use special protective measures because the patient will not feel eye pain, so careful post-operative shielding and follow-up are crucial.NCBI+1Amputation in non-salvageable limbsIn very severe cases with uncontrollable bone infection, extreme deformity, or repeated ulcers that cannot heal, amputation may be considered as a last resort. The aim is to remove a life-threatening source of infection and allow use of a prosthetic limb for better mobility and independence. Decisions are made by a multidisciplinary team and the family after all other options have been tried.MDPI+1Prevention and Lifestyle TipsKeep a strict daily body-check routine.Use protective footwear, helmets, and pads during activities.Avoid walking barefoot, especially outdoors or on hot surfaces.Keep water heaters at safe temperatures and test bath water before use.Maintain good dental and eye care with regular specialist visits.Stay up to date on vaccines and see a doctor quickly for signs of infection.Follow physiotherapy and orthopedic advice to protect joints.Plan safe sports and play with supervision and protective gear.Use safe cooking methods (microwave, guards, oven mitts) and avoid open flames.Have a written emergency and follow-up plan shared with school and caregivers.NCBI+2社会福祉法人日本心身障害児協会+2When to See DoctorsBecause pain does not guide decisions, families should err on the side of caution. Medical attention is needed:For any new swelling, redness, or deformity of a limb, even if there is no complaint of pain.If there is fever, chills, or feeling unwell, which may signal hidden infection.When there is any open wound, especially on feet, joints, or near bones.If there is change in walking pattern, limping, or refusal to use a limb, even without pain.For eye redness, discharge, or vision change, which may indicate corneal damage.Before and after any surgery, in centers that understand CIP.In a medical emergency (trouble breathing, confusion, very high fever), urgent care and local emergency services must be contacted immediately.Cureus+1What to Eat and What to AvoidEat plenty of calcium-rich foods such as milk, yogurt, cheese, or fortified alternatives to support bone strength.Include vitamin-D sources like safe sun exposure, fortified foods, and, if needed, supplements advised by a doctor.Choose lean proteins (fish, eggs, lentils, beans, poultry) to help repair muscles, skin, and bone after injuries or surgery.Fill half the plate with fruits and vegetables to supply vitamins, minerals, and antioxidants for healing and immunity.Use healthy fats such as olive oil, nuts, seeds, and fatty fish to support joint and heart health.Limit sugary drinks and sweets, which add calories but few nutrients and can increase weight, making joint problems worse.Avoid very hard, sharp, or extremely hot foods that can damage teeth, tongue, or mouth without causing pain.Avoid alcohol and recreational drugs, which can further reduce safety awareness and judgment (and are not appropriate for minors).Drink enough water every day to stay hydrated, especially in hot weather, since the person may not feel overheating.Discuss any diet changes or supplements with a doctor or dietitian, especially if other medical conditions are present.MDPIFrequently Asked Questions (FAQs)1. Can channelopathy-associated CIP be cured?No, there is currently no cure that fixes the underlying SCN9A mutation or fully restores normal pain sensation. Treatment focuses on preventing injuries, managing fractures and infections, protecting eyes and teeth, and supporting mental and social well-being. Research into NaV1.7 and related genes may lead to new therapies in the future, but nothing is approved yet.NCBI+12. Is CIP the same as not feeling any sensation at all?No. Most people with channelopathy-associated CIP can feel touch, pressure, and temperature differences, and can move normally. What is mainly missing is the pain signal from injury. This makes life dangerous, because the body’s warning system is silent, but other senses are usually present.MedlinePlus+13. Is channelopathy-associated CIP inherited?Yes. It is autosomal recessive, which means a child must receive one changed SCN9A gene from each parent. Parents are typically healthy carriers. Each pregnancy then has a 25% chance of producing an affected child, a 50% chance of a carrier, and a 25% chance of a non-carrier.NCBI+14. Why is smell often lost in this condition?NaV1.7 channels are also present in olfactory neurons in the nose. When SCN9A is not working, these smell neurons cannot send normal signals, causing complete loss of smell (anosmia) in many patients.MedlinePlus+15. Do people with CIP live a normal life span?Life span can be normal, but only with very careful management. The main dangers are severe infections, fractures, and injuries that go unnoticed and untreated. Early diagnosis, intensive education, and multidisciplinary care greatly improve long-term outcomes.Cureus+16. Can a child with CIP attend regular school?Yes, many children attend regular school, but they need safety plans, trained teachers, and sometimes classroom adaptations. Schools must understand that the child may be badly hurt without complaining, so they must check injuries after falls or accidents, not rely on reports of pain.National Organization for Rare Disorders+17. Why are daily body checks so important?Because pain does not signal problems, visual and physical checks become the “replacement warning system.” Daily inspections catch injuries early, when treatment is simpler and more effective, preventing complications like deformity and infection.社会福祉法人日本心身障害児協会+18. Are there special rules for anesthesia in CIP?Yes. Anesthesiologists must protect the patient from pressure sores, burns, and eye injuries during surgery because the patient cannot report discomfort. They also carefully monitor temperature and blood pressure and follow specific rare-disease guidelines.Orphan Anesthesia9. Can naloxone really make someone with CIP feel pain?Small research studies and case reports show that blocking natural opioids with naloxone or similar drugs can temporarily restore some pain sensation in certain types of NaV1.7-related CIP. However, this is experimental and not a standard therapy, and it must only be done in research settings, not at home.WebMD+110. Is physiotherapy safe if the person cannot feel pain?Physiotherapy is helpful and generally safe when supervised by trained professionals who understand CIP. Therapists watch for swelling, redness, or abnormal movements instead of relying on pain. Exercises are chosen to strengthen muscles and protect joints without heavy impact.Physiopedia+111. Can people with CIP play sports?Yes, but activities should be chosen and adapted with safety in mind. Non-contact or low-impact sports with protective gear and supervision are preferred. High-collision sports (like boxing or rugby) are usually discouraged because serious injuries could occur without pain warning.Physiopedia+112. How often should someone with CIP see doctors?Regular follow-ups with the care team are usually recommended several times per year, plus immediate visits for suspected injuries or illness. Children often need more frequent checks during growth phases when bones and joints change quickly.NCBI+113. Are brothers and sisters at risk?Siblings may be carriers of the SCN9A mutation or, less commonly, also have CIP. Genetic testing and counseling can clarify each sibling’s status and risk for their own children.NCBI+114. What is the role of genetic testing?Genetic testing confirms the diagnosis by identifying SCN9A mutations and helps distinguish CIP from other causes of altered pain, such as different hereditary sensory neuropathies. It also guides family counseling and, in the future, may help match patients to gene-based treatments if they become available.LWW Journals+115. What is the single most important message for families?The most important message is: “No pain does NOT mean no harm.” With careful daily checks, safety planning, and regular specialist care, many injuries and complications can be prevented or caught early. Families should work closely with an experienced medical team and never hesitate to seek medical help when something looks or feels wrong, even if the child is not complaining.NCBI+1Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.The article is written by Team RxHarun and reviewed by the Rx Editorial Board MembersLast Updated: December 21, 2025.PDF Documents For This Disease ConditionRare Diseases and Medical Genetics.[rxharun.com] i2023_IFPMA_Rare_Diseases_Brochure_28Feb2017_FINAL.[rxharun.com] the-UK-rare-diseases-framework.[rxharun.com] National-Recommendations-for-Rare-Disease-Health-Care-Summary.[rxharun.com] History of rare diseases and their genetic.[rxharun.com] health-care-and-rare-disorders.[rxharun.com] Rare Disease Registries.[rxharun.com] autoimmune-Rare-Genetic-Diseases.[rxharun.com] Rare Genetic Diseases.[rxharun.com] rare-disease-day.[rxharun.com] Rare_Disease_Drugs_e.[rxharun.com] fda-CDER-Rare-Diseases-Public-Workshop-Master.[rxharun.com] rare-and-inherited-disease-eligibility-criteria.[rxharun.com] FDA-rare-disease-list.pdf-rxharun.com1 Human-Gene-Therapy-for-Rare Diseases_Jan_2020fda.[rxharun.com]FDA-rare-disease-lists.[rxharun.com] 30212783fnl_Rare Disease.[rxharun.com] FDA-rare-disease-list.[rxharun.com] List of rare disease.[rxharun.com] Genome Res.-2025-Steyaert-755-68.[rxharun.com] uk-practice-guidelines-for-variant-classification-v4-01-2020.[rxharun.com] PIIS2949774424010355.[rxharun.com] hidden-costs-2016.[rxharun.com] B156_CONF2-en.[rxharun.com] IRDiRC_State-of-Play-2018_Final.[rxharun.com] IRDR_2022Vol11No3_pp96_160.[rxharun.com] from-orphan-to-opportunity-mastering-rare-disease-launch-excellence.[rxharun.com] Rare disease fda.[rxharun.com] England-Rare-Diseases-Action-Plan-2022.[rxharun.com] SCRDAC 2024 Report.[rxharun.com] CORD-Rare-Disease-Survey_Full-Report_Feb-2870-2.[rxharun.com] Stats-behind-the-stories-Genetic-Alliance-UK-2024.[rxharun.com] rare-and-inherited-disease-eligibility-criteria-v2.[rxharun.com] ENG_White paper_A4_Digital_FINAL.[rxharun.com] UK_Strategy_for_Rare_Diseases.[rxharun.com] MalaysiaRareDiseaseList.[rxharun.com] EURORDISCARE_FULLBOOKr.[rxharun.com] EMHJ_1999_5_6_1104_1113.[rxharun.com] national-genomic-test-directory-rare-and-inherited-disease-eligibilitycriteria-.[rxharun.com] be-counted-052722-WEB.[rxharun.com] RDI-Resource-Map-AMR_MARCH-2024.[rxharun.com] genomic-analysis-of-rare-disease-brochure.[rxharun.com] List-of-rare-diseases.[rxharun.com] RDI-Resource-Map-AFROEMRO_APRIL[rxharun.com] rdnumbers.[rxharun.com] .Rare disease atoz .[rxharun.com] EmanPublisher_12_5830biosciences-.[rxharun.com]Referenceshttps://www.ncbi.nlm.nih.gov/books/NBK208609/https://pmc.ncbi.nlm.nih.gov/articles/PMC6279436/https://rarediseases.org/rare-diseases/https://rarediseases.info.nih.gov/diseaseshttps://en.wikipedia.org/w/index.php?title=Category:Rare_diseaseshttps://en.wikipedia.org/wiki/List_of_genetic_disordershttps://en.wikipedia.org/wiki/Category:Genetic_diseases_and_disordershttps://medlineplus.gov/genetics/condition/https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/https://www.fda.gov/patients/rare-diseases-fdahttps://www.fda.gov/science-research/clinical-trials-and-human-subject-protection/support-clinical-trials-advancing-rare-disease-therapeutics-start-pilot-programhttps://accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.2134https://www.mayoclinicproceedings.org/article/S0025-6196%2823%2900116-7/fulltexthttps://www.ncbi.nlm.nih.gov/mesh?https://www.rarediseasesinternational.org/working-with-the-who/https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03322-7https://www.rarediseasesnetwork.org/https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rare-diseasehttps://www.raregenomics.org/rare-disease-listhttps://www.astrazeneca.com/our-therapy-areas/rare-disease.htmlhttps://bioresource.nihr.ac.uk/rarehttps://www.roche.com/solutions/focus-areas/neuroscience/rare-diseaseshttps://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/https://www.genomicsengland.co.uk/genomic-medicine/understanding-genomics/rare-disease-genomicshttps://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01026https://wikicure.fandom.com/wiki/Rare_Diseaseshttps://www.wikidoc.org/index.php/List_of_genetic_disordershttps://www.medschool.umaryland.edu/btbank/investigators/list-of-disorders/https://www.orpha.net/en/disease/listhttps://www.genetics.edu.au/SitePages/A-Z-genetic-conditions.aspxhttps://ojrd.biomedcentral.com/https://health.ec.europa.eu/rare-diseases-and-european-reference-networks/rare-diseases_enhttps://bioportal.bioontology.org/ontologies/ORDOhttps://www.orpha.net/en/disease/listhttps://www.fda.gov/industry/medical-products-rare-diseases-and-conditionshttps://www.gao.gov/products/gao-25-106774https://www.gene.com/partners/what-we-are-looking-for/rare-diseaseshttps://www.genome.gov/For-Patients-and-Families/Genetic-Disordershttps://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/https://my.clevelandclinic.org/health/diseases/21751-genetic-disordershttps://globalgenes.org/rare-disease-facts/https://www.nidcd.nih.gov/directory/national-organization-rare-disorders-nordhttps://byjus.com/biology/genetic-disorders/https://www.cdc.gov/genomics-and-health/about/genetic-disorders.htmlhttps://www.genomicseducation.hee.nhs.uk/doc-type/genetic-conditions/https://www.thegenehome.com/basics-of-genetics/disease-exampleshttps://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/https://www.pfizerclinicaltrials.com/our-research/rare-diseaseshttps://clinicaltrials.gov/ct2/results?recrshttps://apps.who.int/gb/ebwha/pdf_files/EB116/B116_3-en.pdfhttps://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239https://www.nibib.nih.gov/https://www.nei.nih.gov/https://oxfordtreatment.com/https://www.nidcd.nih.gov/health/https://consumer.ftc.gov/articles/https://www.nccih.nih.gov/healthhttps://catalog.ninds.nih.gov/https://www.aarda.org/diseaselist/https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheetshttps://www.nibib.nih.gov/https://www.nia.nih.gov/health/topicshttps://www.nichd.nih.gov/https://www.nimh.nih.gov/health/topicshttps://www.nichd.nih.gov/https://www.niehs.nih.gov/https://www.nimhd.nih.gov/https://www.nhlbi.nih.gov/health-topicshttps://obssr.od.nih.gov/.https://www.nichd.nih.gov/health/topicshttps://rarediseases.info.nih.gov/diseaseshttps://beta.rarediseases.info.nih.gov/diseaseshttps://orwh.od.nih.gov/ SaveSavedRemoved 0 PreviousChannelopathy-Associated Congenital Insensitivity to Pain, Autosomal Recessive NextCongenital Insensitivity to Pain–Anosmia–Neuropathic Arthropathy Related ArticlesAdded to wishlistRemoved from wishlist 0 Posterior Membrane Corneal DystrophyAdded to wishlistRemoved from wishlist 0 Endothelial Corneal DystrophyAdded to wishlistRemoved from wishlist 0 Dystrophy of the Corneal EndotheliumAdded to wishlistRemoved from wishlist 0 Chandler Syndrome